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Supplemental Figure Legends: 
Supplemental Fig. 1: TPA induced cleavage of endogenous CD44 in the human breast 
cancer cell line MDA-MB-231. Cleavage is inhibited by batimastat, by the PKC inhibitors 
BIM1 and Gö6976, by okadaic acid and by an active mutant of merlin (see also28,29). 
Supplemental Fig. 2: TPA induced increased chymotrypsin sensitivity of endogenous 
NRG1. 
Supplemental Fig. 3: (A) NRG1-S286A reduces protease accessibility of the NRG1 
ectodomain to chymotrypsin. 
(B) PKCδ knockdown reduces protease accessibility of the NRG1 ectodomain to 
chymotrypsin. 
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